​

Quantum-Si Stock (NASDAQ:QSI)

RevenueOwnershipFinancialsChartTranscripts
Quantum-Si by TradingView

Previous Close

$0.99

52W Range

$0.69 - $3.10

50D Avg

$0.95

200D Avg

$1.24

Market Cap

$187.24M

Avg Vol (3M)

$5.54M

Beta

3.17

Div Yield

-

QSI Company Profile

Quantum-Si incorporated operates within the life sciences sector, focusing on the creation of an advanced platform for individual molecule detection. This innovative technology is designed to streamline sample preparation and subsequent sequencing processes. The company offers a unique, proprietary single molecule detection system that draws on advancements from the semiconductor industry. This system is specifically applied to the field of proteomics, paving the way for next-generation protein sequencing. Established in 2013, Quantum-Si's headquarters are located in Guilford, Connecticut.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

149

IPO Date

Nov 13, 2020

Website

QSI Performance

Revenue Breakdown

Revenue Breakdown by Product/Service

Product/ServiceDec 25Dec 24Dec 23
Product$2.29M$2.92M$1.03M
Service$150.00K$133.00K$51.00K

Fiscal year ends in Dec 25 | Currency in USD

QSI Financial Summary

Dec 25Dec 24Dec 23
Revenue$2.44M$3.06M$1.08M
Operating Income$-116.10M$-108.58M$-111.17M
Net Income$-101.34M$-101.01M$-95.96M
EBITDA$-116.10M$-103.98M$-91.80M
Basic EPS$-0.51$-0.71$-0.68
Diluted EPS$-0.51$-0.71$-0.68

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts

Q1 26May 07, 26 | 4:30 PM
Q4 25Mar 04, 26 | 4:30 PM
Q3 25Nov 05, 25 | 4:30 PM

Peer Comparison

TickerCompany
LBRXLB Pharmaceuticals Inc Common Stock
AUTLAutolus Therapeutics plc
ALTAltimmune, Inc.
ADCTADC Therapeutics S.A.
ANNXAnnexon, Inc.
ENGNenGene Holdings Inc.
SLDBSolid Biosciences Inc.
RCKTRocket Pharmaceuticals, Inc.
DBVTDBV Technologies S.A.
AURAAura Biosciences, Inc.